Long-term treatment of a VIPoma with somatostatin analogue resulting in remission of symptoms and possible shrinkage of metastases.

Aún no traducido Aún no traducido
Categoría Estudio primario
RevistaGastroenterology
Año 1985
A 43-yr-old-man with metastatic VIPoma in whom the conventional measures of surgery, chemotheraphy, and hepatic artery embolization ultimately failed to control his severe diarrhea, resulting from vasoactive intestinal polypeptide hypersecretion, was treated with a new long-acting somatostatin analogue, SMS 201-995, for 14 mo. SMS 201-995 not only controlled the diarrhea without side effects but appeared to have possibly induced a reduction in metastatic tumor size.
Epistemonikos ID: f4b731fb34b3fbeb57b8b7352fa84d172b191d5a
First added on: May 24, 2023